购物车
全部删除
您的购物车当前为空
NF-κB-IN-14 (compound 5e) 能够抑制 LPS诱导的巨噬细胞中一氧化氮生成 (IC50:6.4 μM)。此外,NF-κB-IN-14 会破坏TLR4-MyD88蛋白相互作用,从而抑制NF-κB信号通路。该化合物还可减轻特应性皮炎小鼠模型的耳部水肿和炎症。

NF-κB-IN-14 (compound 5e) 能够抑制 LPS诱导的巨噬细胞中一氧化氮生成 (IC50:6.4 μM)。此外,NF-κB-IN-14 会破坏TLR4-MyD88蛋白相互作用,从而抑制NF-κB信号通路。该化合物还可减轻特应性皮炎小鼠模型的耳部水肿和炎症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
NF-κB-IN-14 相关产品
| 产品描述 | NF-κB-IN-14 (compound 5e) inhibits nitric oxide production in macrophages induced by LPS, with an IC50 of 6.4 μM. It disrupts the interaction between TLR4 and MyD88 proteins, thereby inhibiting the NF-κB signaling pathway. Additionally, NF-κB-IN-14 reduces ear edema and inflammation in a mouse model of atopic dermatitis. |
| 分子量 | 319.19 |
| 分子式 | C15H12Cl2N4 |
| CAS No. | 3019972-01-8 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容